PAUL A. MAHON - 07 Dec 2023 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
07 Dec 2023
Transactions value $
-$726,771
Form type
4
Filing time
07 Dec 2023, 16:30:08 UTC
Previous filing
17 Nov 2023
Next filing
26 Dec 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $707K +6K +16.39% $117.76 42.6K 07 Dec 2023 Direct F1
transaction UTHR Common Stock Sale -$1.41M -5.9K -13.85% $238.88 36.7K 07 Dec 2023 Direct F1, F2
transaction UTHR Common Stock Sale -$24K -100 -0.27% $239.68 36.6K 07 Dec 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Stock Options Options Exercise $0 -6K -5.88% $0.00 96K 07 Dec 2023 Common Stock 6K $117.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 17, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $238.21 to $239.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.